MP99-03 RIOK2 IS A MEDIATOR OF OBESITY ENHANCED PROSTATE CANCER GROWTH
Publication
, Conference
Macias, E; Corcoran, D; Chi, J-T; Freedland, S
Published in: Journal of Urology
April 2017
Duke Scholars
Published In
Journal of Urology
DOI
EISSN
1527-3792
ISSN
0022-5347
Publication Date
April 2017
Volume
197
Issue
4S
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Macias, E., Corcoran, D., Chi, J.-T., & Freedland, S. (2017). MP99-03 RIOK2 IS A MEDIATOR OF OBESITY ENHANCED PROSTATE CANCER GROWTH. In Journal of Urology (Vol. 197). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1016/j.juro.2017.02.3089
Macias, Everardo, David Corcoran, Jen-Tsan Chi, and Stephen Freedland. “MP99-03 RIOK2 IS A MEDIATOR OF OBESITY ENHANCED PROSTATE CANCER GROWTH.” In Journal of Urology, Vol. 197. Ovid Technologies (Wolters Kluwer Health), 2017. https://doi.org/10.1016/j.juro.2017.02.3089.
Macias E, Corcoran D, Chi J-T, Freedland S. MP99-03 RIOK2 IS A MEDIATOR OF OBESITY ENHANCED PROSTATE CANCER GROWTH. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2017.
Macias, Everardo, et al. “MP99-03 RIOK2 IS A MEDIATOR OF OBESITY ENHANCED PROSTATE CANCER GROWTH.” Journal of Urology, vol. 197, no. 4S, Ovid Technologies (Wolters Kluwer Health), 2017. Crossref, doi:10.1016/j.juro.2017.02.3089.
Macias E, Corcoran D, Chi J-T, Freedland S. MP99-03 RIOK2 IS A MEDIATOR OF OBESITY ENHANCED PROSTATE CANCER GROWTH. Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2017.
Published In
Journal of Urology
DOI
EISSN
1527-3792
ISSN
0022-5347
Publication Date
April 2017
Volume
197
Issue
4S
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences
- 1103 Clinical Sciences